Novartis AG vs Snowflake Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Snowflake Inc trades at $271.43 (market cap $95.09B). The key difference: Novartis AG is far larger — about 3.1× Snowflake Inc's market cap, and Novartis AG pays a 3.17% dividend while Snowflake Inc pays none. Which is the better fit depends on your goals.
| NVS | SNOW | |
|---|---|---|
Market Cap | $290.25B | $95.09B |
Sector | Health | Technology |
52-Week High | $168.62 | $280.16 |
52-Week Low | $113.50 | $121.11 |
Enterprise Value | $330.27B | $94.90B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →